128 related articles for article (PubMed ID: 28571905)
1. Extremely small-sized globular poly(ethylene glycol)-cyclic RGD conjugates targeting integrin α
Kim SK; Lee JM; Oh KT; Lee ES
Int J Pharm; 2017 Aug; 528(1-2):1-7. PubMed ID: 28571905
[TBL] [Abstract][Full Text] [Related]
2. pH-Responsive globular poly(ethylene glycol) for photodynamic tumor therapy.
Ku EB; Lee DJ; Na K; Choi SW; Youn YS; Bae SK; Oh KT; Lee ES
Colloids Surf B Biointerfaces; 2016 Dec; 148():173-180. PubMed ID: 27595892
[TBL] [Abstract][Full Text] [Related]
3. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
4. RGD-conjugated solid lipid nanoparticles inhibit adhesion and invasion of αvβ3 integrin-overexpressing breast cancer cells.
Shan D; Li J; Cai P; Prasad P; Liu F; Rauth AM; Wu XY
Drug Deliv Transl Res; 2015 Feb; 5(1):15-26. PubMed ID: 25787336
[TBL] [Abstract][Full Text] [Related]
5. Integrin αvβ3-targeted dynamic contrast-enhanced magnetic resonance imaging using a gadolinium-loaded polyethylene gycol-dendrimer-cyclic RGD conjugate to evaluate tumor angiogenesis and to assess early antiangiogenic treatment response in a mouse xenograft tumor model.
Chen WT; Shih TT; Chen RC; Tu SY; Hsieh WY; Yang PC
Mol Imaging; 2012; 11(4):286-300. PubMed ID: 22954145
[TBL] [Abstract][Full Text] [Related]
6. Alendronate/cRGD-Decorated Ultrafine Hyaluronate Dot Targeting Bone Metastasis.
Lee E; Park J; Youn YS; Oh KT; Kim D; Lee ES
Biomedicines; 2020 Nov; 8(11):. PubMed ID: 33187133
[TBL] [Abstract][Full Text] [Related]
7. Tumor targeting and imaging using cyclic RGD-PEGylated gold nanoparticle probes with directly conjugated iodine-125.
Kim YH; Jeon J; Hong SH; Rhim WK; Lee YS; Youn H; Chung JK; Lee MC; Lee DS; Kang KW; Nam JM
Small; 2011 Jul; 7(14):2052-60. PubMed ID: 21688390
[TBL] [Abstract][Full Text] [Related]
8. Targeted glioma chemotherapy by cyclic RGD peptide-functionalized reversibly core-crosslinked multifunctional poly(ethylene glycol)-b-poly(ε-caprolactone) micelles.
Fang Y; Jiang Y; Zou Y; Meng F; Zhang J; Deng C; Sun H; Zhong Z
Acta Biomater; 2017 Mar; 50():396-406. PubMed ID: 28065871
[TBL] [Abstract][Full Text] [Related]
9. A tumor-targeting cRGD-EGFR siRNA conjugate and its anti-tumor effect on glioblastoma in vitro and in vivo.
He S; Cen B; Liao L; Wang Z; Qin Y; Wu Z; Liao W; Zhang Z; Ji A
Drug Deliv; 2017 Nov; 24(1):471-481. PubMed ID: 28181832
[TBL] [Abstract][Full Text] [Related]
10. Targeted systemic delivery of siRNA to cervical cancer model using cyclic RGD-installed unimer polyion complex-assembled gold nanoparticles.
Yi Y; Kim HJ; Mi P; Zheng M; Takemoto H; Toh K; Kim BS; Hayashi K; Naito M; Matsumoto Y; Miyata K; Kataoka K
J Control Release; 2016 Dec; 244(Pt B):247-256. PubMed ID: 27590214
[TBL] [Abstract][Full Text] [Related]
11. Nano-Self Assembled Photosensitizer Composed of Methoxy Poly(ethylene glycol)-Conjugated Chlorin e6 for Enhanced Photosensing of HCT116 Cells.
Chung CW; Choi CW; Jeong YI; Kang DH
J Nanosci Nanotechnol; 2016 Feb; 16(2):1379-83. PubMed ID: 27433590
[TBL] [Abstract][Full Text] [Related]
12. Failure of active targeting by a cholesterol-anchored ligand and improvement by altering the lipid composition to prevent ligand desorption.
Yamamoto S; Sakurai Y; Harashima H
Int J Pharm; 2018 Jan; 536(1):42-49. PubMed ID: 29126905
[TBL] [Abstract][Full Text] [Related]
13. Chlorin e6 Conjugated Poly(dopamine) Nanospheres as PDT/PTT Dual-Modal Therapeutic Agents for Enhanced Cancer Therapy.
Zhang D; Wu M; Zeng Y; Wu L; Wang Q; Han X; Liu X; Liu J
ACS Appl Mater Interfaces; 2015 Apr; 7(15):8176-87. PubMed ID: 25837008
[TBL] [Abstract][Full Text] [Related]
14. pH-Sensitive self-assembling nanoparticles for tumor near-infrared fluorescence imaging and chemo-photodynamic combination therapy.
Hou W; Zhao X; Qian X; Pan F; Zhang C; Yang Y; de la Fuente JM; Cui D
Nanoscale; 2016 Jan; 8(1):104-16. PubMed ID: 26607263
[TBL] [Abstract][Full Text] [Related]
15. Cyclic RGD peptide-modified liposomal drug delivery system for targeted oral apatinib administration: enhanced cellular uptake and improved therapeutic effects.
Song Z; Lin Y; Zhang X; Feng C; Lu Y; Gao Y; Dong C
Int J Nanomedicine; 2017; 12():1941-1958. PubMed ID: 28331317
[TBL] [Abstract][Full Text] [Related]
16. α
Zhong P; Meng H; Qiu J; Zhang J; Sun H; Cheng R; Zhong Z
J Control Release; 2017 Aug; 259():176-186. PubMed ID: 27986551
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of novel cRGD-paclitaxel conjugates for integrin-assisted drug delivery.
Pilkington-Miksa M; Arosio D; Battistini L; Belvisi L; De Matteo M; Vasile F; Burreddu P; Carta P; Rassu G; Perego P; Carenini N; Zunino F; De Cesare M; Castiglioni V; Scanziani E; Scolastico C; Casiraghi G; Zanardi F; Manzoni L
Bioconjug Chem; 2012 Aug; 23(8):1610-22. PubMed ID: 22770429
[TBL] [Abstract][Full Text] [Related]
18. cRGD Peptide-Conjugated Pyropheophorbide-a Photosensitizers for Tumor Targeting in Photodynamic Therapy.
Li W; Tan S; Xing Y; Liu Q; Li S; Chen Q; Yu M; Wang F; Hong Z
Mol Pharm; 2018 Apr; 15(4):1505-1514. PubMed ID: 29502410
[TBL] [Abstract][Full Text] [Related]
19. Multiarm Nanoconjugates for Cancer Cell-Targeted Delivery of Photosensitizers.
Zhao Y; Li F; Mao C; Ming X
Mol Pharm; 2018 Jul; 15(7):2559-2569. PubMed ID: 29764120
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and pharmacological evaluation of a novel PEG-cRGD-conjugated irinotecan derivative as potential antitumor agent.
Huang YQ; Yuan JD; Ding HF; Song YS; Qian G; Wang JL; Ji M; Zhang Y
Eur J Med Chem; 2018 Oct; 158():82-90. PubMed ID: 30199708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
